AbscivsAbbott Laboratories

ABSI and ABT stock compared: price, dividend, valuation and results, from SEC filings.

ABSI

Absci Corporation

$7.59

Value $1.3B

+1.54%
ABSI's page

ABT

Abbott Laboratories

$104.87

Value $182B

-2.37%
ABT's page

Absci (ABSI) has a market value of $1.3B and Abbott Laboratories (ABT) $182B. Over the last year, with dividends, ABSI moved +169.1% and ABT -17.7%. Dividend yield: ABSI none, ABT 2.40%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABSI$1.3B

    ABT$182B

    ABT is 139 times ABSI

  • Revenue, 12 months

    ABSI$1.5M

    ABT$48.2B

    ABT is 32,434 times ABSI

  • Net income, 12 months

    ABSI-$126M

    ABT$4.7B

  • Operating margin

    ABSI-8,812.3%

    ABT13.8%

    8,826.1 points apart

  • ROIC

    ABSI-49.6%

    ABT6.3%

    55.9 points apart

  • P/E

    ABSI–

    ABT38.8

  • Dividend yield

    ABSI0.0%

    ABT2.4%

    2.4 points apart

  • 5-year return

    ABSI-37.1%

    ABT-11.5%

    25.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABSI-37.1%

ABT-11.5%

5010020222023202420252026
Returns by period
PeriodABSIWith dividendsABTWith dividends
1 year since November 14, 2025+169.1%Price +169.1%-17.7%Price -19.7%
3 years since November 17, 2023+423.4%+73.6% a yearPrice +423.4%+12.2%+3.9% a yearPrice +5.4%
5 years since November 16, 2021-37.1%-8.9% a yearPrice -37.1%-11.5%-2.4% a yearPrice -19.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABSIAbsciABTAbbott Laboratories

Valuation

ABSIABT
Valuation
Price$7.59$104.87
Market value$1.3B$182B
Enterprise value (EV)$1.1B$209B
P/E–38.8
P/E, 5-year median–33.7
P/B6.03.6
EV/EBIT–31.5
Free cash flow yield–3.7%

Results and growth

ABSIABT
Results and growth
Revenue, 12 months$1.5M$48.2B
Net income, 12 months-$126M$4.7B
Free cash flow, 12 months-$113M$6.8B
Earnings per share, 12 months-$0.78$2.69
Revenue growth, year on year-38.2%5.7%
Revenue growth a year, past-7.4%over 5 years+5.1%over 5 years
EPS growth a year, past–+8.3%over 5 years

Margins and returns on capital

ABSIABT
Margins and returns on capital
Gross margin–56.9%
Operating margin-8,812.3%13.8%
Net margin-8,451.3%9.8%
ROIC-49.6%6.3%
ROE-60.6%9.1%

Balance sheet

ABSIABT
Balance sheet
Cash$174M$4.3B
Total debt$3.3M$31.2B
Net debt / EBITDA–3.3
Interest cover-2,569.4×6.7×

Dividends and buybacks

ABSIABT
Dividends and buybacks
Dividend yield–2.4%
Dividend per share, 12 months–$2.52
Dividend growth a year, past–+10.4%over 5 years
Buyback yield–0.5%
Shareholder yield–2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABSI or ABT

Didn't find what you were looking for?

Ask us
Which is bigger, Absci or Abbott Laboratories?

By market value, Abbott Laboratories ($182B) is about 139.0 times Absci ($1.3B), at today's prices.

How did ABSI and ABT stock do over the last 5 years?

Since November 16, 2021, ABSI's price moved -37.1% and ABT's -19.9%. With dividends: ABSI -37.1% (-8.9% a year), ABT -11.5% (-2.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABSI or ABT?

The dividend yield at today's price is none for Absci and 2.40% for Abbott Laboratories. Over the last twelve months they paid – and $2.52 per share.

Which has the higher profit margins, Absci or Abbott Laboratories?

Over the last twelve months, the net margin was -8,451.3% for Absci and 9.8% for Abbott Laboratories, and the operating margin -8,812.3% and 13.8%. Revenue was $1.5M and $48.2B.

Which is the better investment, Absci or Abbott Laboratories?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.